Harvard Bioscience (HBIO) – Analyst Ratings
-
Harvard Bioscience Inc. (HBIO) PT Raised to $6.75 at Singular Research
-
Harvard Bioscience Inc. (HBIO) PT Raised to $7 at Benchmark, 'Q1 Beat & Raise; Outlook Improving; Raising Price Target'
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to HBIO Stock Lookup